| Q34521121 | Access to Primary and Preventive Care among Foreign‐Born Adults in Canada and the United States |
| Q30489067 | Adherence to therapy for Barrett's esophagus-associated neoplasia |
| Q34977603 | Coping strategies used by patients infected with hepatitis C virus who are facing medication costs. |
| Q37627254 | Cost-related non-adherence to prescribed medicines among older adults: a cross-sectional analysis of a survey in 11 developed countries. |
| Q37437033 | Cost-related nonadherence to medications among patients with diabetes and chronic pain: factors beyond finances |
| Q37735874 | Cost-related nonadherence to prescribed medicines among older Canadians in 2014: a cross-sectional analysis of a telephone survey |
| Q58761551 | Cost-related nonadherence to prescription medications in Canada: a scoping review |
| Q58117486 | Cost-related underuse of medications in older adults: ELSI-Brazil |
| Q46187014 | Effect of racial differences on ability to afford prescription medications |
| Q54518600 | Effets potentiels d’un modèle rationnel de prescription sur les dépenses nationales en santé: Plus d’un demi-milliard de dollars en économies annuelles. |
| Q46021277 | Is Canadian Healthcare Affordable? A Comparative Analysis of the Canadian Healthcare System from 2004 to 2014. |
| Q41080901 | Out-of-pocket costs and adherence to antihypertensive agents among older adults covered by the public drug insurance plan in Quebec |
| Q37265102 | Out-of-pocket prices of opioid analgesics in the United States, 1999-2004 |
| Q60054781 | Patterns of borrowing to finance out-of-pocket prescription drug costs in Canada: a descriptive analysis |
| Q37174306 | Potential effects of rational prescribing on national health care spending: More than half a billion dollars in annual savings |
| Q41195521 | Preparing for pre-exposure prophylaxis: perceptions and readiness of Canadian pharmacists for the implementation of HIV pre-exposure prophylaxis |
| Q59133098 | Prescription drug coverage in Canada: a review of the economic, policy and political considerations for universal pharmacare |
| Q37716304 | Prescription medication changes following direct-to-consumer personal genomic testing: findings from the Impact of Personal Genomics (PGen) Study |
| Q36797126 | Socioeconomic disadvantage and pain |
| Q91966144 | Spending on World Health Organization essential medicines in Medicare Part D, 2011-15: retrospective cost analysis |
| Q35761548 | The effect of cost on adherence to prescription medications in Canada |
| Q28069734 | Universal prescription drug coverage in Canada: Long-promised yet undelivered |
| Q36565336 | Use of Compassionate Supply of Antiretroviral Drugs to Avoid Treatment Interruptions or Delayed Treatment Initiation among HIV-Positive Patients Living in Ontario: A Retrospective Review |